-
公开(公告)号:EP1513814A1
公开(公告)日:2005-03-16
申请号:EP03733139.4
申请日:2003-05-29
发明人: TAKAHASHI, Masami , MIYAKE, Tsutomu,8-59-601, Motoyamaminami-machi , MORITANI, Yasunori , ASAI, Hidetoshi , ISHII, Taketoshi , KONO, Rikako,Towa City Coop 401
IPC分类号: C07D211/46 , C07D211/58 , C07D211/62 , C07D211/54 , C07D211/74 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D417/04 , C07D417/12 , C07D473/34 , A61K31/451 , A61K31/454 , A61K31/4545 , A61K31/4709 , A61K31/497 , A61K31/513
CPC分类号: C07D211/46 , A61K38/00 , C07D211/54 , C07D211/58 , C07D211/62 , C07D211/74 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/04 , C07D409/12 , C07D417/04 , C07D417/12 , C07D473/34 , C07K5/0202 , C07K5/06191 , C07K5/0808 , C07K5/0812 , C07K5/0821 , C07K5/1008
摘要: The present invention provides a novel piperidine compound of the formula [I]: wherein Ring A represents an optionally substituted benzene ring, Ring B represents an optionally substituted benzene ring, R1 represents an optionally substituted alkyl group, an optionally substituted hydroxyl group, etc., or a group of the formula: (a) wherein R11 and R12 are the same or different, and each represents hydrogen atom, a substituted carbonyl group, a substituted sulfonyl group, an optionally substituted alkyl group, etc., R2 represents hydrogen atom, etc., Z represents oxygen atom or a group represented by -N(R3)-, R3 represents hydrogen atom or an alkyl group, etc., R4 represents hydrogen atom or an alkyl group, etc.,or a pharmaceutically acceptable salt thereof.